TB-500 vs SS-31: Mechanism, Half-Life & Research Use
TB-500 and SS-31 represent two distinct biochemical strategies in preclinical regenerative medicine and cellular homeostasis models. While TB-500 operates via actin monomer sequestration and endothelial migration to promote macro-tissue repair, SS-31 selectively targets inner mitochondrial membrane cardiolipin to restore bioenergetics and minimize oxidative stress.
Quick answer
TB-500 and SS-31 represent two distinct biochemical strategies in preclinical regenerative medicine and cellular homeostasis models. While TB-500 operates via actin monomer sequestration and endothelial migration to promote macro-tissue repair, SS-31 selectively targets inner mitochondrial membrane cardiolipin to restore bioenergetics and minimize oxidative stress.
Key takeaways
- [TB-500](/research-peptides/tb-500) and [SS-31](/research-peptides/ss-31) differ fundamentally in their primary subcellular target and metabolic role.
- | Technical Parameter | [TB-500](/research-peptides/tb-500) (Thymosin Beta-4 Fragment) | SS-31 (Elamipretide) | | :--- | :--- | :--- | | **Primary Target** | Monomeric G-Actin / Endothelial Receptors | Inner Mitochondrial Membrane Cardiolipin | | **Mechanistic Class** | Cytoskeletal & Angiogenic Regeneration Peptide | Mitochondria-Targeted Bioenergetics / Antioxidant | | **Molecular Formula** | C212H350N56O78S | C32H49N9O5 | | **Molecular Mass** | 4963.50 g/mol | 639.80 g/mol | | **Reported In Vivo Half-Life** | ~2 to 4 hours (systemic clearance) | ~2 to 3 hours (plasma), rapidly localized to mitochondria | | **Solubility Profile** | Highly soluble in Sterile Water / Bacteriostatic Water | Highly soluble in Aqueous Buffers / PBS / Water | | **Primary Preclinical Models** | Muscle rupture, tendon injury, ischemic tissue repair | Ischemia-reperfusion, cardiotoxicity, metabolic/neurodegenerative decay | | **Vial Formats Available** | 2mg, 5mg, [TB-500 10mg](/product/tb-500-thymosin-beta-4-10mg) lyophilized powder | 10mg, 50mg lyophilized powder |
- [TB-500](/research-peptides/tb-500) is a synthetic analog of the naturally occurring 43-amino-acid peptide Thymosin Beta-4, specifically retaining the active LKKTET hexapeptide motif responsible for actin-binding activity.
- [SS-31](/research-peptides/ss-31) (D-Arg-2',6'-Dmt-Lys-Phe-NH2), also designated as Elamipretide or Bendavia, is a water-soluble, cell-permeable aromatic-cationic tetrapeptide designed specifically to accumulate within the inner mitochondrial membrane (IMM).
Direct Comparison: TB-500 vs SS-31 at a Glance
TB-500 and SS-31 differ fundamentally in their primary subcellular target and metabolic role. TB-500 is a synthetic fragment of Thymosin Beta-4 that sequesters G-actin monomers to promote cell motility, angiogenesis, and extracellular matrix remodeling during soft-tissue repair. In contrast, SS-31 (Elamipretide) is a tetrapeptide that selectively binds cardiolipin in the inner mitochondrial membrane, stabilizing cristae architecture, optimizing electron transport chain efficiency, and reducing reactive oxygen species (ROS) production.
To assist laboratory researchers in structuring controlled comparative assays, the following technical matrix outlines the key biochemical, structural, and operational parameters of both research compounds.
Comparative Specification Criteria
| Technical Parameter | TB-500 (Thymosin Beta-4 Fragment) | SS-31 (Elamipretide) | | :--- | :--- | :--- | | **Primary Target** | Monomeric G-Actin / Endothelial Receptors | Inner Mitochondrial Membrane Cardiolipin | | **Mechanistic Class** | Cytoskeletal & Angiogenic Regeneration Peptide | Mitochondria-Targeted Bioenergetics / Antioxidant | | **Molecular Formula** | C212H350N56O78S | C32H49N9O5 | | **Molecular Mass** | 4963.50 g/mol | 639.80 g/mol | | **Reported In Vivo Half-Life** | ~2 to 4 hours (systemic clearance) | ~2 to 3 hours (plasma), rapidly localized to mitochondria | | **Solubility Profile** | Highly soluble in Sterile Water / Bacteriostatic Water | Highly soluble in Aqueous Buffers / PBS / Water | | **Primary Preclinical Models** | Muscle rupture, tendon injury, ischemic tissue repair | Ischemia-reperfusion, cardiotoxicity, metabolic/neurodegenerative decay | | **Vial Formats Available** | 2mg, 5mg, TB-500 10mg lyophilized powder | 10mg, 50mg lyophilized powder |
Researchers evaluating structural tissue regeneration against intracellular organelle stabilization can cross-reference these criteria when designing multi-arm protocols across our comprehensive catalog of reference-grade research peptides.
TB-500 Mechanism: Actin Sequestration and Cytoskeletal Dynamics
TB-500 is a synthetic analog of the naturally occurring 43-amino-acid peptide Thymosin Beta-4, specifically retaining the active LKKTET hexapeptide motif responsible for actin-binding activity. In extracellular and intracellular environments, monomeric G-actin sequestration by TB-500 prevents premature polymerization into F-actin filaments. This dynamic flux facilitates rapid cell migration, lamellipodia formation, and coordinated movement of endothelial cells and fibroblasts into damaged tissue sites.
Preclinical rodent models demonstrate that TB-500 functions primarily as a regeneration peptide, investigated for promoting cell migration, blood-vessel formation, and flexibility during soft-tissue and muscle-fiber recovery. In vitro endothelial cell migration assays indicate that TB-500 upregulates matrix metalloproteinases (MMPs), facilitating matrix turnover and capillary sprouting (angiogenesis). Consequently, in vivo research designs frequently employ TB-500 in models of lacerated skeletal muscle, damaged cardiac tissue following myocardial ischemia, and compromised dermal structures.
SS-31 Mechanism: Inner Mitochondrial Membrane and Cardiolipin Stabilization
SS-31 (D-Arg-2',6'-Dmt-Lys-Phe-NH2), also designated as Elamipretide or Bendavia, is a water-soluble, cell-permeable aromatic-cationic tetrapeptide designed specifically to accumulate within the inner mitochondrial membrane (IMM). The peptide interacts electrostatic-hydrophobically with cardiolipin, an essential phospholipid exclusive to the IMM that regulates cristae structure and anchors electron transport chain (ETC) complexes.
By stabilizing the cardiolipin-cytochrome c complex, SS-31 prevents electron leakage from Complexes I and III, thereby inhibiting the downstream formation of damaging reactive oxygen species (ROS). Preclinical studies suggest that SS-31 maintains optimal mitochondrial membrane potential (ΔΨm), enhances ATP synthesis efficiency under hypoxic conditions, and prevents the opening of the mitochondrial permeability transition pore (mPTP), mitigating apoptotic signaling in ischemic and metabolic disease models.
Pharmacokinetics, Half-Life, and Metabolism in Preclinical Models
Pharmacokinetic evaluations of TB-500 in rodent and non-human primate assays demonstrate rapid systemic distribution followed by steady elimination. Due to its peptide structure, free TB-500 exhibits a plasma half-life of approximately 2 to 4 hours, undergoing proteolysis into smaller metabolic fragments by serum endopeptidases. Despite its relatively brief circulating half-life, the downstream signaling cascades triggered by actin binding—such as focal adhesion kinase (FAK) activation and extracellular matrix reorganization—persist significantly longer within target tissues.
SS-31 exhibits rapid uptake into intracellular compartments upon systemic or local administration in rodent models. Systemic plasma half-life is measured at approximately 2 hours; however, its high affinity for cardiolipin results in prolonged retention within mitochondrial membranes across renal, cardiac, and neuronal tissues. SS-31 is resistant to typical aminopeptidase degradation due to the inclusion of D-arginine and dimethyltyrosine residues, yielding improved metabolic stability in cell culture media and tissue lysates compared to standard unmodified peptides.
Experimental Study Designs: Selecting TB-500 vs SS-31
Selecting between TB-500 and SS-31 depends entirely on the primary scientific endpoints of the investigative model. When the research objective revolves around macro-structural tissue repair, capillary bed expansion, or myofibrillar reorganization following mechanical trauma, TB-500 provides the appropriate mechanistic pathway. Its capacity to mobilize progenitor cells and modulate inflammatory cytokine production makes it ideal for soft-tissue and orthopedic repair protocols.
Conversely, if the research protocol focuses on cellular senescence, mitochondrial bioenergetics, oxidative stress reduction, or ischemia-reperfusion injury, SS-31 is the superior choice. SS-31 allows investigators to isolate mitochondrial dysfunction without confounding variables related to actin-driven structural cell migration. For protocols examining complex pathology involving both oxidative damage and structural breakdown, certain dual-arm study designs explore parallel or sequential administration of both compounds.
Reconstitution and Laboratory Storage Standards
Both TB-500 and SS-31 are supplied as sterile, lyophilized powders to ensure long-term chemical stability. To prevent degradation, un-reconstituted vials should be stored at -20°C or -80°C away from direct light. Prior to reconstitution, vials should be allowed to equilibrate to room temperature to minimize condensation inside the container.
Reconstitution should be performed using sterile, laboratory-grade Bacteriostatic Water or Sterile Normal Saline depending on the sensitivity of the downstream assay. For accurate molar concentration adjustments, researchers should utilize our interactive reconstitution calculator. Following reconstitution, aqueous peptide solutions should be aliquoted into single-use micro-centrifuge tubes to prevent destructive freeze-thaw cycles and stored at -20°C. Analytical testing demonstrates that reconstituted solutions retain verified potency for up to 30 days when refrigerated at 2°C–8°C.
Comparative Peptide Ecosystem: Related Regenerative and Metabolic Compounds
To contextualize the properties of TB-500 and SS-31 within the broader landscape of biochemical research reagents, it is useful to evaluate them alongside comparable molecules. In musculoskeletal and vascular regeneration models, researchers frequently compare TB-500 with BPC-157, a synthetic pentadecapeptide that acts through VEGFR2 signaling and nitric oxide pathway modulation, as well as GHK-Cu, a copper-binding tripeptide involved in collagen synthesis and remodeling.
Similarly, in mitochondrial bioenergetics and cellular longevity frameworks, SS-31 is often studied alongside MOTS-c, a mitochondrial-derived peptide that regulates nuclear gene expression during metabolic stress, and SS-31 product variants. Establishing multi-compound research arms allows investigators to map complementary cellular pathways ranging from membrane-bound receptor signaling to organelle-specific metabolic enhancement.
Quality Assurance, Purity, and COA Verification at PX1 Research
Experimental reproducibility relies fundamentally on peptide purity, sequence fidelity, and the complete absence of biological contaminants. PX1 Research manufactures all research compounds within USA-based, GMP-compliant facilities adhering to ISO 9001 and ISO 17025 laboratory quality standards. Every batch undergoes rigorous dual-stage analytical testing, including High-Performance Liquid Chromatography (HPLC) to verify structural purity (>99%) and Mass Spectrometry (MS) to confirm exact molecular weight.
Furthermore, every lot undergoes chromogenic LAL assay testing to confirm endotoxin levels remain strictly below <0.01 EU/mg, preventing confounding inflammatory responses in sensitive cell lines or animal tissues. Researchers can instantly download batch-specific Certificates of Analysis for every inventory item. Detailed technical documentation and bulk procurement options are accessible via our dedicated wholesale research accounts portal.
Frequently Asked Questions
How do the molecular mechanisms of TB-500 and SS-31 differ?
TB-500 functions primarily by binding and sequestering monomeric G-actin, facilitating cell motility, wound healing, and angiogenesis. SS-31 selectively targets inner mitochondrial membrane cardiolipin, reducing electron leakage, lowering ROS production, and enhancing ATP synthesis.
What preclinical models are best suited for TB-500 research?
TB-500 is commonly evaluated in preclinical models of muscle tears, tendon/ligament injuries, corneal damage, dermal wound healing, and post-ischemic cardiac tissue recovery.
What preclinical models are best suited for SS-31 research?
SS-31 is typically investigated in models of acute kidney injury, heart failure, neurodegenerative pathology, skeletal muscle atrophy, and age-related mitochondrial dysfunction.
Are TB-500 and SS-31 suitable for human consumption or veterinary administration?
No. Both TB-500 and SS-31 sold by PX1 Research are strictly intended for laboratory research use only (in vitro and preclinical animal models). They are not cleared or intended for human or veterinary clinical use.
What solvent should be used to reconstitute TB-500 and SS-31?
Both peptides readily dissolve in Bacteriostatic Water or sterile phosphate-buffered saline (PBS). Avoid aggressive vortexing; gentle inversion or swirling is recommended to achieve full dissolution.
How does PX1 Research verify the purity and endotoxin limits of these peptides?
Every lot is analyzed in an ISO 17025 accredited laboratory via RP-HPLC for purity (>99%) and ESI-MS for structural mass verification. Chromogenic LAL testing ensures endotoxin levels remain below 0.01 EU/mg.
Can TB-500 and SS-31 be co-administered in the same experimental assay?
In preclinical research, dual-arm protocols sometimes evaluate both compounds to observe potential synergistic effects between microvascular regeneration (TB-500) and mitochondrial energetic recovery (SS-31). However, physical mixing in a single vial before storage is generally avoided to prevent physical aggregation.
Where can researchers obtain batch COAs for TB-500 and SS-31?
Batch-specific Certificates of Analysis featuring full HPLC chromatograms and mass spectra are publicly accessible directly on our website via the dedicated COA lookup tool.
Related pages
All products are sold strictly for laboratory and research use only. Not for human or veterinary use, diagnosis, treatment or consumption. Statements have not been evaluated by the FDA.